Neutralizing monoclonal antibody mAb114 for Ebola virus disease (EVD)
2 August 2022
| Toolkit
Overview
Both mAb114 and REGN-EB3 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.WHO Team
Editors
World Health Organization
Number of pages
1
Reference numbers
WHO Reference Number: WHO/EVD/therapeutics/mAb114/Poster_A/2022.1
Copyright
